Results 251 to 260 of about 2,314,627 (288)

Hydrogel Beads Loaded with Glucosinolate-Rich <i>Brassicaceae</i> Extract as a Controlled-Release Alternative to Biofumigation. [PDF]

Molecules
Baglioni M, Clemente I, Nardin R, Bisozzi F, Costantini S, Fattori G, Tamasi G, Rossi C.   +7 more
europepmc   +1 more source

Controlled Release of Perillyl Alcohol via pH-Responsive Chitosan-Polypyrrole Nanocarriers. [PDF]

ACS Omega
Borges MMC, de Carvalho SYB, Borges KB, Guimarães LGL.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Paroxetine Controlled Release

CNS Drugs, 2004
A controlled-release (CR) formulation of the SSRI paroxetine has been developed. This CR formulation delays the release of paroxetine until the tablet has passed through the stomach; the drug is then released over 4-5 hours. In well designed placebo-controlled trials in patients with major depressive disorder (including a study in the elderly), social ...
Lynne M, Bang, Gillian M, Keating
openaire   +2 more sources

Controlled-release microchips

Expert Opinion on Drug Delivery, 2006
Efficient drug delivery remains an important challenge in medicine: continuous release of therapeutic agents over extended time periods in accordance with a predetermined temporal profile; local delivery at a constant rate to the tumour microenvironment to overcome much of the systemic toxicity and to improve antitumour efficacy; improved ease of ...
Sadhana, Sharma, A Jasper, Nijdam, Piyush M, Sinha, Robbie J, Walczak, Xuewu, Liu, Mark M-C, Cheng, Mauro, Ferrari   +6 more
openaire   +2 more sources

Controlled-Release Carvedilol

American Journal of Cardiovascular Drugs, 2008
▴ A new once-daily controlled-release (CR) capsule formulation of the nonselective β- and α1-adrenoceptor antagonist carvedilol is now available for use in the treatment of essential hypertension, heart failure (HF), and left ventricular dysfunction following myocardial infarction (MI).
Natalie J, Carter, Gillian M, Keating
openaire   +2 more sources

Steroid control of gonadotropin release

Journal of Steroid Biochemistry, 1975
Abstract Several studies have led to the concept that the length of the rat estrous cycle is dependent on the timing of estrogen (E) secretion. According to this hypothesis E secretion during the 5-day cycle is delayed. However, we have found LH and E levels in both 4 and 5 day cycles are identical.
L G, Nequin, J, Alvarez, N B, Schwartz
openaire   +2 more sources

Controlling cavitation for controlled release

2009 IEEE International Ultrasonics Symposium, 2009
We present a novel, long-lived ultrasound contrast vehicle with triggered drug release capability. The vehicle comprises shell-stabilized microbubbles encapsulated within the aqueous core of a vesicle-like microcapsule. Encapsulating microbubbles enhances their longevity as ultrasound contrast agents by shielding the microbubbles from dissolution in a ...
Steven Wrenn, Stephen Dicker, Eleanor Small, Michal Mleczko   +3 more
openaire   +1 more source

Implantable controlled release systems

Pharmacology & Therapeutics, 1983
PIP: A controlled release system utilizes a polymer matrix or pump as a rate-controlling device to deliver the drug in a fixed, predetermined pattern for a desired time period. These systems have the following advantages compared to other methods of administration: 1) plasma drug levels are continuously maintained in a therapeutically desirable range ...
openaire   +2 more sources

Electrochemically controlled release

Journal of Controlled Release, 1987
Abstract In vitro experiments on iontophoretic delivery of model anions: acetate, benzoate, hexanoate and dodecanoate, at constant current through hairless mouse skin show that smaller ions are delivered more efficiently and that flux-concentration −1 current −1 is nearly constant.
Larry L. Miller, Gregory A. Smith, null An-Cheng Chang, null Qin-Xin Zhou   +3 more
openaire   +1 more source